PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+23.8%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$376M
AUM Growth
+$376M
(+6.8%)
Cap. Flow
-$14M
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
43
Reduced
26
Closed
20
Top Buys
| 1 |
Humana
HUM
|
$8.93M |
| 2 |
Vaxcyte
PCVX
|
$7.58M |
| 3 |
United Therapeutics
UTHR
|
$5.13M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$4.93M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Top Sells
| 1 |
CVS Health
CVS
|
$11.2M |
| 2 |
Waters Corp
WAT
|
$6.45M |
| 3 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$5.16M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$4.14M |
| 5 |
IQVIA
IQV
|
$4.06M |
Sector Composition
| 1 | Healthcare | 98.13% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $28M | 7.46% | 100,702 +18,432 | +22% | +$5.13M |
|
2
Boston Scientific
BSX
$156B
| $17M | 4.53% | 367,933 +20,146 | +6% | +$932K |
|
3
UnitedHealth
UNH
$281B
| $14.7M | 3.92% | 27,742 +101 | +0.4% | +$53.5K |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $13.9M | 3.7% | 116,333 -1,067 | -0.9% | -$127K |
|
5
Eli Lilly
LLY
$657B
| $12.6M | 3.35% | 34,438 -847 | -2% | -$310K |
|
|
VRNA
6
Verona Pharma
VRNA
$9.16B
| $10.8M | 2.88% | 414,448 +91,175 | +28% | +$2.38M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $10.5M | 2.8% | 81,854 +9,457 | +13% | +$1.22M |
|
8
Haemonetics
HAE
$2.63B
| $10.4M | 2.77% | 132,378 +16,581 | +14% | +$1.3M |
|
9
Danaher
DHR
$147B
| $10.2M | 2.71% | 38,393 -14,613 | -28% | -$3.88M |
|
10
Xenon Pharmaceuticals
XENE
$2.98B
| $9.29M | 2.47% | 235,491 +12,894 | +6% | +$508K |
|
|
11
Humana
HUM
$36.5B
| $8.93M | 2.38% | +17,439 | New | +$8.93M |
|
|
CTIC
12
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $8.47M | 2.25% | 1,408,642 +198,497 | +16% | +$1.19M |
|
|
13
Vaxcyte
PCVX
$4B
| $7.58M | 2.02% | +158,048 | New | +$7.58M |
|
14
DexCom
DXCM
$29.5B
| $7.1M | 1.89% | 62,730 +22,372 | +55% | +$2.53M |
|
|
CNCE
15
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $7.03M | 1.87% | 1,203,484 +65,897 | +6% | +$385K |
|
16
Sutro Biopharma
STRO
$72.7M
| $7M | 1.86% | 865,975 +178,640 | +26% | +$1.44M |
|
17
Elevance Health
ELV
$71.8B
| $6.31M | 1.68% | 12,296 -4,900 | -28% | -$2.51M |
|
18
Tenet Healthcare
THC
$16.3B
| $6.17M | 1.64% | 126,505 -32,519 | -20% | -$1.59M |
|
19
Keros Therapeutics
KROS
$618M
| $6.09M | 1.62% | 126,790 +26,863 | +27% | +$1.29M |
|
|
CDMO
20
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.9M | 1.57% | 428,268 +23,450 | +6% | +$323K |
|
|
DCPH
21
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $5.65M | 1.51% | 344,920 +43,028 | +14% | +$705K |
|
22
MannKind Corp
MNKD
$1.41B
| $5.43M | 1.45% | 1,031,109 +106,130 | +11% | +$559K |
|
23
Ionis Pharmaceuticals
IONS
$6.79B
| $5.33M | 1.42% | 141,115 -100,830 | -42% | -$3.81M |
|
24
Insulet
PODD
$23.9B
| $5.31M | 1.41% | 18,042 +988 | +6% | +$291K |
|
25
Esperion Therapeutics
ESPR
$448M
| $5.13M | 1.36% | 822,784 +526,403 | +178% | +$3.28M |
|